Free Trial

SONOVA (OTCMKTS:SONVY) Sees Strong Trading Volume - Here's What Happened

SONOVA logo with Medical background

Key Points

  • SONOVA experienced a notable increase in trading volume, with 40,245 shares traded, reflecting a 74% rise compared to the previous session.
  • Analyst ratings for SONOVA are mixed, with one firm upgrading it to a Strong Buy, while several others have downgraded it to a Strong Sell.
  • The stock is currently trading at $55.24, down 0.4%, and has a 50-day moving average of $57.54.
  • Five stocks to consider instead of Sonova.

SONOVA HOLDING (OTCMKTS:SONVY - Get Free Report) shares saw an uptick in trading volume on Monday . 40,245 shares were traded during mid-day trading, an increase of 74% from the previous session's volume of 23,159 shares.The stock last traded at $55.24 and had previously closed at $55.45.

Wall Street Analyst Weigh In

Several research firms have recently commented on SONVY. BNP Paribas lowered shares of SONOVA from a "strong-buy" rating to a "strong sell" rating in a research report on Wednesday, June 11th. Barclays lowered shares of SONOVA from a "hold" rating to a "strong sell" rating in a research report on Friday, June 20th. Kepler Capital Markets upgraded shares of SONOVA from a "strong sell" rating to a "hold" rating in a research report on Friday, June 6th. Zacks Research upgraded shares of SONOVA from a "strong sell" rating to a "hold" rating in a research report on Thursday, August 28th. Finally, Sanford C. Bernstein upgraded shares of SONOVA from a "hold" rating to a "strong-buy" rating in a research report on Friday, July 18th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Hold rating and four have given a Sell rating to the company's stock. Based on data from MarketBeat.com, SONOVA presently has an average rating of "Reduce".

Read Our Latest Stock Analysis on SONOVA

SONOVA Trading Down 0.4%

The stock's 50-day moving average is $57.54 and its 200-day moving average is $59.35. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.96 and a current ratio of 1.27.

About SONOVA

(Get Free Report)

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Sonova Right Now?

Before you consider Sonova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.

While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.